Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: JAMA Ophthalmol. 2013 Apr 1;131(4):514–521. doi: 10.1001/jamaophthalmol.2013.2299

Table 1.

Descriptive statistics for the entire cohort

Fifths of hsCRP

CRP (n=1350) 1 2 3 4 5
(mean, SD) (mg/L) 0.178 (0.796) 0.477 (0.095) 0.873 (0.156) 1.725 (0.424) 7.168 (6.577)
range 0.1–0.31 0.32–0.63 0.64–1.16 1.17–2.66 2.67–45.2

% Assigned to intensive insulin therapy 48.5 48.4 48.2 52.2 53.1

% in Primary prevention subcohort 52.3 56.0 52.5 49.3 44.3

Age (mean, SD) 24.81 (7.12) 26.51 (7.26) 27.29 (7.06) 28.44 (6.85) 27.16 (6.60)

% Males 77.3 60.4 49.6 44.1 32.8

% White 95.0 97.4 96.7 98.2 94.8

Duration of type I diabetes (months) (mean, SD) 66.6 (47.8) 63.0 (48.7) 66.5 (48.9) 70.7 (49.1) 79.3 (52.5)

Baseline Glycosolated Hemoglobin (mean, %, SD) 8.7 (1.5) 8.8 (1.6) 8.9 (1.6) 8.9 (1.6) 9.2 (1.6)

Baseline BMI (kg/m2, SD) 22.3 (2.6) 23.2 (2.7) 23.4 (2.6) 24.1 (2.9) 24.0 (2.9)

Baseline LDL (mg/dl, SD) 102.02 (28.4) 107.35 110.92 (29.2) 117.12 (1.6) 111.08 (26.2)

Baseline Ratio of Total Cholesterol to HDL (SD) 3.46 (0.9) 3.55 (0.8) 3.69 (1.0) 3.80 (1.1) 3.69 (1.0)

% Never Smokers 74.3 67.8 64.9 60.7 57.6